{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:25Z","timestamp":1707525385747},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,18]]},"DOI":"10.7759\/cureus.47272","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T17:12:16Z","timestamp":1697649136000},"source":"Crossref","is-referenced-by-count":0,"title":["The Decrease in Serum Total Cholesterol and Low-Density Lipoprotein (LDL) Concentrations With the Initiation of Hemodialysis Despite a Concomitant Increase in Serum Albumin Concentrations"],"prefix":"10.7759","author":[{"given":"Ramin","family":"Sam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine S","family":"Tuot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafia","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal","volume":"17","author":"Chan MK","year":"1982","unstructured":"Chan MK, Varghese Z, Persaud JW, Baillod RA, Moorhead JF. Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal. Clin Nephrol. 1982, 17:183-90.","journal-title":"Clin Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.239","article-title":"Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment","volume":"47","author":"H\u00f6rkk\u00f6 S","year":"1995","unstructured":"H\u00f6rkk\u00f6 S, Huttunen K, Kes\u00e4niemi YA. Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment. Kidney Int. 1995, 47:1732-40. 10.1038\/ki.1995.239","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V371409","article-title":"Improvement of plasma lipoprotein profiles during high-flux dialysis","volume":"3","author":"Seres DS","year":"1993","unstructured":"Seres DS, Strain GW, Hashim SA, Goldberg IJ, Levin NW. Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol. 1993, 3:1409-15. 10.1681\/ASN.V371409","journal-title":"J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000170259","article-title":"Improvement in lipid profiles and triglyceride removal in patients on polyamide membrane hemodialysis","volume":"14","author":"de Pr\u00e9cigout V","year":"1996","unstructured":"de Pr\u00e9cigout V, Higueret D, Larroumet N, et al.. Improvement in lipid profiles and triglyceride removal in patients on polyamide membrane hemodialysis. Blood Purif. 1996, 14:170-6. 10.1159\/000170259","journal-title":"Blood Purif"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2012.01096.x","article-title":"Contribution of high flux membranes to the therapy of uremia-associated dyslipidemia","volume":"16","author":"Azak A","year":"2012","unstructured":"Azak A, Huddam B, \u00d6ne\u00e7 K, Ko\u00e7ak G, Dede F, Ayl\u0131 D, Duranay M. Contribution of high flux membranes to the therapy of uremia-associated dyslipidemia. Ther Apher Dial. 2012, 16:595-9. 10.1111\/j.1744-9987.2012.01096.x","journal-title":"Ther Apher Dial"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent C","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, et al.. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011, 377:2181-92. 10.1016\/S0140-6736(11)60739-3","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000345176","article-title":"Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations","volume":"35","author":"Vaziri ND","year":"2013","unstructured":"Vaziri ND, Norris KC. Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations. Blood Purif. 2013, 35:31-6. 10.1159\/000345176","journal-title":"Blood Purif"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.225185","article-title":"The cardiovascular risk factor profiles among end-stage renal failure patients treated with continuous ambulatory peritoneal dialysis and intermittent hemodialysis","volume":"29","author":"Zamiah SA","year":"2018","unstructured":"Zamiah SA, Draman CR, Seman MR, Safhan AF, Rozalina R, Nik Ruzni NI. The cardiovascular risk factor profiles among end-stage renal failure patients treated with continuous ambulatory peritoneal dialysis and intermittent hemodialysis. Saudi J Kidney Dis Transpl. 2018, 29:114-9. 10.4103\/1319-2442.225185","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/sdi.12706","article-title":"ESRD-induced dyslipidemia-should management of lipid disorders differ in dialysis patients?","volume":"31","author":"Moradi H","year":"2018","unstructured":"Moradi H, Streja E, Vaziri ND. ESRD-induced dyslipidemia-should management of lipid disorders differ in dialysis patients?. Semin Dial. 2018, 31:398-405. 10.1111\/sdi.12706","journal-title":"Semin Dial"},{"key":"ref10","article-title":"Use of hemodiafiltration to enhance delivered dialysis","volume":"40","author":"Wei SS","year":"1994","unstructured":"Wei SS, Paganini EP, Cressman MD, Wright E. Use of hemodiafiltration to enhance delivered dialysis. ASAIO J. 1994, 40:977-80.","journal-title":"ASAIO J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-200105000-00014","article-title":"Do high-flux dialysis membranes affect renal dyslipidemia?","volume":"47","author":"Ottosson P","year":"2001","unstructured":"Ottosson P, Attman PO, Knight C, Samuelsson O, Weiss L, Alaupovic P. Do high-flux dialysis membranes affect renal dyslipidemia?. ASAIO J. 2001, 47:229-34. 10.1097\/00002480-200105000-00014","journal-title":"ASAIO J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000348453","article-title":"Impact of low- or high-flux haemodialysis and online haemodiafiltration on inflammatory markers and lipid profile in chronic haemodialysis patients","volume":"35","author":"Akoglu H","year":"2013","unstructured":"Akoglu H, Dede F, Piskinpasa S, Falay MY, Odabas AR. Impact of low- or high-flux haemodialysis and online haemodiafiltration on inflammatory markers and lipid profile in chronic haemodialysis patients. Blood Purif. 2013, 35:258-64. 10.1159\/000348453","journal-title":"Blood Purif"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m BC","year":"2009","unstructured":"Fellstr\u00f6m BC, Jardine AG, Schmieder RE, et al.. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009, 360:1395-407. 10.1056\/NEJMoa0810177","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw360","article-title":"Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study","volume":"33","author":"Solbu MD","year":"2018","unstructured":"Solbu MD, Mj\u00f8en G, Mark PB, et al.. Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study. Nephrol Dial Transplant. 2018, 33:102-12. 10.1093\/ndt\/gfw360","journal-title":"Nephrol Dial Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013501997","article-title":"Safety and efficacy of statins in patients with end-stage renal disease","volume":"47","author":"Nemerovski CW","year":"2013","unstructured":"Nemerovski CW, Lekura J, Cefaretti M, Mehta PT, Moore CL. Safety and efficacy of statins in patients with end-stage renal disease. Ann Pharmacother. 2013, 47:1321-9. 10.1177\/1060028013501997","journal-title":"Ann Pharmacother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/21897.8523","article-title":"A comparative study of lipid profile and cardiovascular risk biomarkers among chronic haemodialysis patients and healthy individuals","volume":"10","author":"Lokesh S","year":"2016","unstructured":"Lokesh S, Kadavanu TM, Green SR, et al.. A comparative study of lipid profile and cardiovascular risk biomarkers among chronic haemodialysis patients and healthy individuals. J Clin Diagn Res. 2016, 10:OC15-9. 10.7860\/JCDR\/2016\/21897.8523","journal-title":"J Clin Diagn Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.10.031","article-title":"Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study","volume":"133","author":"Eckart A","year":"2020","unstructured":"Eckart A, Struja T, Kutz A, et al.. Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. Am J Med. 2020, 133:713-22. 10.1016\/j.amjmed.2019.10.031","journal-title":"Am J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2015.11.016","article-title":"Intradialytic parenteral nutrition in maintenance hemodialysis patients suffering from protein-energy wasting. Results of a multicenter, open, prospective, randomized trial","volume":"36","author":"Marsen TA","year":"2017","unstructured":"Marsen TA, Beer J, Mann H. Intradialytic parenteral nutrition in maintenance hemodialysis patients suffering from protein-energy wasting. Results of a multicenter, open, prospective, randomized trial. Clin Nutr. 2017, 36:107-17. 10.1016\/j.clnu.2015.11.016","journal-title":"Clin Nutr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow GM","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002, 62:245-52. 10.1046\/j.1523-1755.2002.00434.x","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2015.39.5.353","article-title":"Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia","volume":"39","author":"Parhofer KG","year":"2015","unstructured":"Parhofer KG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J. 2015, 39:353-62. 10.4093\/dmj.2015.39.5.353","journal-title":"Diabetes Metab J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner C","year":"2005","unstructured":"Wanner C, Krane V, M\u00e4rz W, Olschewski M, Mann JF, Ruf G, Ritz E. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005, 353:238-48. 10.1056\/NEJMoa043545","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)33546-9","article-title":"The in vitro metabolism of mevalonate by sterol and non-sterol pathways","volume":"251","author":"Righetti M","year":"1976","unstructured":"Righetti M, Wiley MH, Murrill PA, Siperstein MD. The in vitro metabolism of mevalonate by sterol and non-sterol pathways. J Biol Chem. 1976, 251:2716-21.","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosissup.2004.08.027","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994","volume":"5","author":"Pedersen TR","year":"2004","unstructured":"Pedersen TR, Kjekshus J, Berg K, et al.. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl. 2004, 5:81-7. 10.1016\/j.atherosclerosissup.2004.08.027","journal-title":"Atheroscler Suppl"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon CP","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, et al.. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004, 350:1495-504. 10.1056\/NEJMoa040583","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/180233-the-decrease-in-serum-total-cholesterol-and-low-density-lipoprotein-ldl-concentrations-with-the-initiation-of-hemodialysis-despite-a-concomitant-increase-in-serum-albumin-concentrations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:14Z","timestamp":1707509474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/180233-the-decrease-in-serum-total-cholesterol-and-low-density-lipoprotein-ldl-concentrations-with-the-initiation-of-hemodialysis-despite-a-concomitant-increase-in-serum-albumin-concentrations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.47272","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,18]]}}}